Life Sciences Precision Medicine Software sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Precision Medicine Software
1.1 - About Life Sciences Precision Medicine Software sector
Companies in the Life Sciences Precision Medicine Software category build platforms that ingest and analyze genomic, transcriptomic, and clinical data to guide targeted therapy development and patient-level decisions. These companies deliver integrated pipelines, analytics, and decision support to accelerate biomarker discovery, enable companion diagnostics, and power personalized care pathways. M&A analysts seeking strategic buyers in precision medicine software will encounter providers focused on interoperable, compliant, and clinically validated solutions.
Offerings typically include genomic data management and variant interpretation tools that translate sequencing outputs into clinically actionable findings. Vendors provide multi‑omics integration pipelines and AI‑driven patient stratification to identify biomarker‑defined cohorts, plus trial matching modules that connect patients to precision trials. Many add real‑world evidence analytics, HL7/FHIR interoperability, and regulatory compliance frameworks to support companion diagnostic development and embed clinical decision support within electronic health records.
Primary customers include biopharma R&D teams, clinical genomics laboratories, and health system precision medicine programs. These solutions help reduce trial enrollment times, increase diagnostic yield, and improve therapy selection accuracy while lowering development risk and cost. By operationalizing biomarker discovery and patient stratification, organizations can accelerate companion diagnostic approvals, expand access to targeted treatments, and demonstrate measurable clinical and economic outcomes.
2. Buyers in the Life Sciences Precision Medicine Software sector
2.1 Top strategic acquirers of Life Sciences Precision Medicine Software companies
Tempus
- Description: Provider of data-driven precision medicine solutions, including genomic profiling, pharmacogenomic testing, AI-powered imaging analytics and interoperable clinical integrations that deliver actionable insights for clinicians to improve diagnosis, treatment selection and research collaboration across oncology, cardiovascular disease and other conditions.
- Key Products:
- Analytical Machine Learning Platform: AI-driven system that analyzes expansive clinical and molecular data in real time, enabling physicians to choose personalized therapies based on actionable insights during patient care
- Tempus Next: Care pathway intelligence platform that identifies biomarker testing gaps, supports guideline-directed decisions, and helps oncologists deliver appropriate breast cancer treatments using integrated data analytics
- Tempus One Clinical Assistant: On-demand digital tool that streamlines complex clinical and genomic data, giving providers rapid, clear patient insights while reducing workflow burden through AI-enabled automation
- Fixed PDO Panels: Preclinical oncology R&D panels allowing researchers to test drug candidates—including small molecules, mAbs
- ADCs, cell and bispecific therapies—on patient-derived organoids to assess efficacy across modalities
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Precision Medicine Software sector
M&A buyer group 1: Bioinformatics Platforms
Benchling
- Type: N/A
- Employees: ●●●●●
- Description: Provider of cloud-based scientific software for life science R&D that powers the Benchling R&D Cloud, enabling over 1,300 biotechnology companies to capture, manage, and analyze experimental data with modern tools, expert support, and a community of best practices.
- Key Products:
- Solution Accelerators: Pre-built Benchling configurations with data models, templates, dashboards and end-to-end workflows for cell and gene therapy, antibodies, etc., offering experimental tracking, sample management, and process modeling for up to 50% faster delivery and higher data consistency
- Benchling Learning Labs: Online, on-demand training platform where users and partners gain essential Benchling skills and certifications on R&D and administration tasks, boosting digital competencies in labs
- Success Packages: Comprehensive support bundles delivering product optimization, administration, and expert scientific and technical services to configure software and ensure high-quality outcomes for complex workflows
- Benchling R&D Cloud Platform: Unified cloud software that powers biotechnology research, digitizing laboratory processes and enabling data-driven, scalable, and efficient modern R&D operations.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Precision Medicine Software sector
3.1 - Buyout funds in the Life Sciences Precision Medicine Software sector
2.2 - Strategic buyer groups for Life Sciences Precision Medicine Software sector
4 - Top valuation comps for Life Sciences Precision Medicine Software companies
4.2 - Public trading comparable groups for Life Sciences Precision Medicine Software sector
Valuation benchmark group 1: Genomics Tools and Precision Diagnostics Companies
Ford
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of a range of trucks, commercial cars and vans, sport utility vehicles, and luxury vehicles worldwide; offers retail installment sale contracts and direct financing leases for new vehicles; sells vehicles, service parts, and accessories through distributors and dealers; provides wholesale loans to dealers for vehicle inventory purchase and dealership operations.
- Key Products:
- Trucks: Range of Ford trucks with varied functionalities for different use cases
- Commercial Vehicles: Vans and commercial cars suitable for business applications
- Luxury Vehicles: Premium Lincoln-branded vehicles with advanced features and luxury
- Retail Financing: Retail installment sale contracts and direct financing leases for vehicle purchases
- Fleet Solutions: Wholesale loans to dealers for vehicle inventory and dealership operations.